Aflac Incorporated (NYSE:AFL) Given Average Rating of “Hold” by Brokerages

Shares of Aflac Incorporated (NYSE:AFLGet Free Report) have earned a consensus rating of “Hold” from the thirteen brokerages that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $82.15.

Several analysts have commented on the stock. StockNews.com lowered shares of Aflac from a “hold” rating to a “sell” rating in a research report on Wednesday, April 10th. Morgan Stanley lifted their target price on shares of Aflac from $80.00 to $84.00 and gave the stock an “equal weight” rating in a research note on Monday, April 15th. The Goldman Sachs Group lifted their target price on shares of Aflac from $61.00 to $75.00 and gave the stock a “sell” rating in a research note on Tuesday, January 9th. Wells Fargo & Company reduced their price target on shares of Aflac from $83.00 to $81.00 and set an “equal weight” rating for the company in a research report on Thursday, April 11th. Finally, UBS Group raised their price target on shares of Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 10th.

Check Out Our Latest Stock Report on AFL

Insider Activity

In related news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total value of $423,100.00. Following the completion of the sale, the director now owns 17,920 shares of the company’s stock, valued at approximately $1,516,390.40. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, Director Arthur Reginald Collins sold 3,000 shares of the business’s stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total value of $239,190.00. Following the completion of the sale, the director now owns 5,592 shares of the company’s stock, valued at approximately $445,850.16. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the completion of the sale, the director now directly owns 17,920 shares of the company’s stock, valued at approximately $1,516,390.40. The disclosure for this sale can be found here. Insiders sold a total of 46,493 shares of company stock valued at $3,765,706 in the last three months. 0.90% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Aflac

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Fortitude Family Office LLC acquired a new stake in Aflac during the 4th quarter worth $25,000. Atwood & Palmer Inc. boosted its stake in Aflac by 80.0% during the 1st quarter. Atwood & Palmer Inc. now owns 315 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 140 shares during the last quarter. Bruce G. Allen Investments LLC acquired a new stake in Aflac during the 4th quarter worth $32,000. Impact Partnership Wealth LLC boosted its stake in Aflac by 471.4% during the 3rd quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 330 shares during the last quarter. Finally, Criterion Capital Advisors LLC acquired a new stake in Aflac during the 4th quarter worth $33,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Stock Performance

AFL stock opened at $83.73 on Friday. The firm has a market cap of $48.18 billion, a price-to-earnings ratio of 10.80, a PEG ratio of 2.30 and a beta of 0.91. The firm has a 50-day simple moving average of $82.61 and a two-hundred day simple moving average of $81.71. Aflac has a one year low of $64.10 and a one year high of $86.26. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.06 and a current ratio of 0.06.

Aflac (NYSE:AFLGet Free Report) last released its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.25 EPS for the quarter, missing the consensus estimate of $1.47 by ($0.22). The firm had revenue of $3.78 billion for the quarter, compared to analysts’ expectations of $4.44 billion. Aflac had a net margin of 24.92% and a return on equity of 17.59%. During the same period in the previous year, the company posted $1.29 earnings per share. On average, equities analysts forecast that Aflac will post 6.41 EPS for the current fiscal year.

Aflac Company Profile

(Get Free Report

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Articles

Analyst Recommendations for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.